Rosacea Treatment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Russia, China - Size and Forecast 2024-2028

Published: Feb 2024

Pages: 170

SKU: IRTNTR77434

Snapshot

Rosacea Treatment Market Forecast 2024-2028

The Rosacea Treatment Market size is forecast to increase by USD 744.29 million, at a CAGR of 6.2% between 2023 and 2028.

There has been an increasing focus on personalized treatment approaches. Personalized treatment approaches play a crucial role in driving the growth of the market. In addition, as the understanding of rosacea has deepened among medical professionals, researchers, and patients, it has become increasingly evident that the condition manifests differently in different people, with varying triggers, symptoms, and treatment responses. Therefore, this recognition has fueled a shift toward personalized treatment strategies tailored to the specific needs of and symptoms in each patient. Hence, such factors are positively impacting the market.

What will be the Size of the Rosacea Treatment Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Segmentation

Distribution Channel Analysis

The hospital pharmacies segment is estimated to witness significant growth during the forecast period. The hospital pharmacies segment plays a major role in providing comprehensive care for rosacea patients, providing a wide range of treatment options that are tailored to individual needs and preferences. In addition, within hospital settings, pharmacists work closely with dermatologists and other healthcare providers to ensure optimal management symptoms as well as complications.

Get a glance at the market contribution of various segments Download PDF Sample

The hospital pharmacies segment was the largest segment and was valued at USD 833.94 million in 2018. Moreover, hospital pharmacies typically stock a variety of topical medications, oral medications, and injectable treatments that are commonly used ensuring that patients have access to the most appropriate therapies for their condition. In addition, topical medications are a cornerstone of , and hospital pharmacies often carry a range of such formulations, including creams, gels, and foams. Furthermore, pharmacists can provide guidance on the selection of the appropriate topical treatment based on factors such as the severity of the disease, skin type, and treatment goals. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Route Of Administration Analysis

Topical medications are a major aspect , providing targeted relief for the characteristic symptoms of the condition, including facial redness, papules, and pustules. In addition, topical treatments for rosacea are typically administered directly to affected skin areas, providing localized action while minimizing other systemic side effects. Moreover, one of the most commonly prescribed topical treatments for rosacea is metronidazole gel or cream, which has anti-inflammatory and antimicrobial properties. Furthermore, Metronidazole helps reduce redness and inflammation associated with rosacea while also targeting the underlying bacteria that contribute to the development of the condition. In addition, another frequently used topical medication is azelaic acid, which exerts anti-inflammatory effects and helps normalize skin cell turnover, thereby reducing the formation of papules and pustules. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Oral

Oral medications are mainly prescribed for the treatment of rosacea, especially in cases where topical treatments alone are insufficient to control symptoms or when the condition is severe. In addition, oral medications for rosacea target inflammation, vascular abnormalities, and the underlying pathophysiological processes that contribute to the development of symptoms. Moreover, one of the most widely used oral medications for rosacea is oral antibiotics, such as doxycycline, minocycline, and tetracycline. In addition, these antibiotics possess anti-inflammatory properties and can help reduce inflammation and redness associated with rosacea by targeting bacterial proliferation in the skin. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 46% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The rosacea treatment market in North America has been witnessing significant growth fuelled by the increase in the geriatric population and a high prevalence of chronic and infectious skin diseases, which has raised the demand for rosacea treatment in this region. In addition, growing awareness about diagnostic tests for dermatological conditions among the geriatric population, especially in the US, has increased the demand for rosacea treatment in the country. Moreover, the aging population in North America, especially in the US and Canada, is likely to contribute to the expansion of the market. Furthermore, increasing healthcare expenditure and investments in research and development activities aimed at developing innovative therapies for rosacea are expected to drive market growth in the region during the forecast period.

Buy Full Report Now

Key Rosacea Treatment Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 18 market companies, including:

Aclaris Therapeutics Inc: The company offers rosacea treatment through HOFADE oxymetazoline hydrochloride topical cream. This is a FDA approved prescription treatment indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamic and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.

Key Drivers

The rising awareness of rosacea, characterized by redness and other symptoms, is a pivotal factor propelling market expansion. Increased consciousness and detection of rosacea play significant roles in fostering the global market's growth trajectory. Moreover, notable efforts in public awareness campaigns, educational programs, and media coverage spotlight the often overlooked and underdiagnosed nature of rosacea.

Consequently, more individuals are recognizing the signs and symptoms of rosacea, resulting in heightened patient self-referrals and proactive dialogues with healthcare providers regarding potential diagnoses and treatments. Furthermore, improvements in medical education and training have empowered healthcare professionals, including dermatologists, primary care physicians, and nurse practitioners, to better identify and diagnose rosacea in clinical settings. Hence, these elements drive market growth throughout the forecast period.

Significant Trends

A key factor shaping the market growth is the rising focus on combination therapies. As the understanding of the complex pathophysiology of rosacea increases, it becomes very evident that the condition often involves multiple underlying factors, including inflammation, vascular abnormalities, and microbial dysregulation. As a result, a one-size-fits-all approach to rosacea treatment may not be sufficient to address the diverse and interconnected aspects of the condition effectively.

Moreover, combination therapies offer a multifaceted approach by simultaneously targeting different pathogenic mechanisms underlying the condition. For instance, a combination of topical agents such as antibiotics, azelaic acid, and anti-inflammatory agents can help reduce inflammation, control bacterial overgrowth, and improve skin barrier function, thereby addressing multiple aspects of rosacea pathology in a synergistic manner. Hence, such factors are driving the market growth during the forecast period.

Major Challenges

Side effects and safety concerns related are one of the key challenges hindering the market growth. While the different medications and procedures are available to manage rosacea symptoms, they can often be accompanied by severe side effects that impact adherence to treatment, patient satisfaction, and overall market expansion. In addition, topical medications that are commonly prescribed for rosacea, such as antibiotics, azelaic acid, and retinoids, may cause skin irritation, dryness, and hypersensitivity reactions in some individuals.

Moreover, these side effects can be particularly problematic for patients with sensitive skin or underlying dermatological conditions, leading to the discontinuation of treatment or reluctance to start therapy. In addition, oral medications, including antibiotics, isotretinoin, and anti-inflammatory agents, are associated with a range of systemic side effects that may limit their long-term use. Furthermore, antibiotics, for example, can disrupt the normal balance of the gut microbiome, leading to gastrointestinal disturbances and increasing the risk of antibiotic resistance. Hence, such factors are hindering the market growth during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Market Analyst Overview

In addressing rosacea, characterized by flushing and visible blood vessels, the treatment market aims to alleviate symptoms and improve quality of life. With rising incidence, public needs prompt efforts to develop efficient interventions that save time. Topical and oral medications, laser therapy, and lifestyle modifications constitute key approaches. Ongoing research ensures innovative solutions, meeting evolving prevalence of rosacea from patient needs and advancing care standards for this prevalent skin disorder.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides a market research and growth analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028.

Distribution Channel Outlook
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Route Of Administration Outlook
- Topical
- Oral
- Injectable
Region Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of the World (ROW)
  - Australia
  - Argentina
  - Brazil

Rosacea Treatment Market Scope
Report Coverage	Details
Page number	170
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 6.2%
Market Growth 2024-2028	USD 744.29 million
Market structure	Fragmented
YoY growth 2023-2024(%)	5.75
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 46%
Key countries	US, Germany, UK, Russia, and China
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	AbbVie Inc., Aclaris Therapeutics Inc., AKUMS, Bausch Health Companies Inc., Croda International Plc, Dermata Therapeutics Inc., Galderma SA, Glenmark Pharmaceuticals Ltd., Hovione, Journey Medical Corp., LEO Pharma AS, Lupin Ltd., Maruho Co. Ltd., Mayne Pharma Group Ltd., Pfizer Inc., PruGen LLC, Sol-Gel Technologies Ltd., Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Zydus Lifesciences Ltd.
Market dynamics	Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Rosacea Treatment Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the rosacea treatment market between 2023 and 2028
Precise estimation of the size and its contribution to the market in focus on the parent market
Detailed market analysis and report of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies position and classification
Accurate predictions about upcoming market growth and trends and changes in consumer behavior
Growth of the market industry across North America, Europe, Asia, and the Rest of the World (ROW)
Thorough market growth and forecasting analysis of the market’s competitive landscape and detailed information about rosacea treatment market companies
Comprehensive market growth analysis of factors that will challenge the growth of rosacea treatment market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global rosacea treatment market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global rosacea treatment market 2018 - 2022 ($ million)

4.2 Distribution Channel Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ million)

4.3 Route of Administration Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Route of Administration Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

6.1 Market segments
- Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)

6.2 Comparison by Distribution Channel
- Exhibit 32: Chart on Comparison by Distribution Channel
- Exhibit 33: Data Table on Comparison by Distribution Channel

6.3 Hospital pharmacies - Market size and forecast 2023-2028
- Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)

6.4 Retail pharmacies - Market size and forecast 2023-2028
- Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)

6.5 Online pharmacies - Market size and forecast 2023-2028
- Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Distribution Channel
- Exhibit 46: Market opportunity by Distribution Channel ($ million)
- Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Route of Administration

7.1 Market segments
- Exhibit 48: Chart on Route of Administration - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Route of Administration - Market share 2023-2028 (%)

7.2 Comparison by Route of Administration
- Exhibit 50: Chart on Comparison by Route of Administration
- Exhibit 51: Data Table on Comparison by Route of Administration

7.3 Topical - Market size and forecast 2023-2028
- Exhibit 52: Chart on Topical - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Topical - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Topical - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Topical - Year-over-year growth 2023-2028 (%)

7.4 Oral - Market size and forecast 2023-2028
- Exhibit 56: Chart on Oral - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Oral - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Oral - Year-over-year growth 2023-2028 (%)

7.5 Injectable - Market size and forecast 2023-2028
- Exhibit 60: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
- Exhibit 61: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
- Exhibit 62: Chart on Injectable - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Injectable - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by Route of Administration
- Exhibit 64: Market opportunity by Route of Administration ($ million)
- Exhibit 65: Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2023-2028 (%)
- Exhibit 68: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)

9.10 UK - Market size and forecast 2023-2028
- Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.11 Russia - Market size and forecast 2023-2028
- Exhibit 103: Chart on Russia - Market size and forecast 2023-2028 ($ million)
- Exhibit 104: Data Table on Russia - Market size and forecast 2023-2028 ($ million)
- Exhibit 105: Chart on Russia - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on Russia - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ million)
- Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption

11.4 Industry risks
- Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 113: Vendors covered

12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification

12.3 Aclaris Therapeutics Inc.
- Exhibit 115: Aclaris Therapeutics Inc. - Overview
- Exhibit 116: Aclaris Therapeutics Inc. - Business segments
- Exhibit 117: Aclaris Therapeutics Inc. - Key news
- Exhibit 118: Aclaris Therapeutics Inc. - Key offerings
- Exhibit 119: Aclaris Therapeutics Inc. - Segment focus

12.4 Bausch Health Companies Inc.
- Exhibit 120: Bausch Health Companies Inc. - Overview
- Exhibit 121: Bausch Health Companies Inc. - Business segments
- Exhibit 122: Bausch Health Companies Inc. - Key news
- Exhibit 123: Bausch Health Companies Inc. - Key offerings
- Exhibit 124: Bausch Health Companies Inc. - Segment focus

12.5 Croda International Plc
- Exhibit 125: Croda International Plc - Overview
- Exhibit 126: Croda International Plc - Business segments
- Exhibit 127: Croda International Plc - Key news
- Exhibit 128: Croda International Plc - Key offerings
- Exhibit 129: Croda International Plc - Segment focus

12.6 Galderma SA
- Exhibit 130: Galderma SA - Overview
- Exhibit 131: Galderma SA - Product / Service
- Exhibit 132: Galderma SA - Key news
- Exhibit 133: Galderma SA - Key offerings

12.7 Glenmark Pharmaceuticals Ltd.
- Exhibit 134: Glenmark Pharmaceuticals Ltd. - Overview
- Exhibit 135: Glenmark Pharmaceuticals Ltd. - Product / Service
- Exhibit 136: Glenmark Pharmaceuticals Ltd. - Key offerings

12.8 Journey Medical Corp.
- Exhibit 137: Journey Medical Corp. - Overview
- Exhibit 138: Journey Medical Corp. - Product / Service
- Exhibit 139: Journey Medical Corp. - Key offerings

12.9 LEO Pharma AS
- Exhibit 140: LEO Pharma AS - Overview
- Exhibit 141: LEO Pharma AS - Business segments
- Exhibit 142: LEO Pharma AS - Key offerings
- Exhibit 143: LEO Pharma AS - Segment focus

12.10 Lupin Ltd.
- Exhibit 144: Lupin Ltd. - Overview
- Exhibit 145: Lupin Ltd. - Product / Service
- Exhibit 146: Lupin Ltd. - Key news
- Exhibit 147: Lupin Ltd. - Key offerings

12.11 Maruho Co. Ltd.
- Exhibit 148: Maruho Co. Ltd. - Overview
- Exhibit 149: Maruho Co. Ltd. - Product / Service
- Exhibit 150: Maruho Co. Ltd. - Key offerings

12.12 Mayne Pharma Group Ltd.
- Exhibit 151: Mayne Pharma Group Ltd. - Overview
- Exhibit 152: Mayne Pharma Group Ltd. - Business segments
- Exhibit 153: Mayne Pharma Group Ltd. - Key news
- Exhibit 154: Mayne Pharma Group Ltd. - Key offerings
- Exhibit 155: Mayne Pharma Group Ltd. - Segment focus

12.13 Pfizer Inc.
- Exhibit 156: Pfizer Inc. - Overview
- Exhibit 157: Pfizer Inc. - Product / Service
- Exhibit 158: Pfizer Inc. - Key news
- Exhibit 159: Pfizer Inc. - Key offerings

12.14 Sol-Gel Technologies Ltd.
- Exhibit 160: Sol-Gel Technologies Ltd. - Overview
- Exhibit 161: Sol-Gel Technologies Ltd. - Product / Service
- Exhibit 162: Sol-Gel Technologies Ltd. - Key offerings

12.15 Taro Pharmaceutical Industries Ltd.
- Exhibit 163: Taro Pharmaceutical Industries Ltd. - Overview
- Exhibit 164: Taro Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 165: Taro Pharmaceutical Industries Ltd. - Key offerings

12.16 Teva Pharmaceutical Industries Ltd.
- Exhibit 166: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 167: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 168: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 169: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 170: Teva Pharmaceutical Industries Ltd. - Segment focus

12.17 Zydus Lifesciences Ltd.
- Exhibit 171: Zydus Lifesciences Ltd. - Overview
- Exhibit 172: Zydus Lifesciences Ltd. - Business segments
- Exhibit 173: Zydus Lifesciences Ltd. - Key offerings
- Exhibit 174: Zydus Lifesciences Ltd. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 175: Inclusions checklist
- Exhibit 176: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 177: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 178: Research methodology
- Exhibit 179: Validation techniques employed for market sizing
- Exhibit 180: Information sources

13.5 List of abbreviations
- Exhibit 181: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

rosacea treatment market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis